Developer docs
API playgroundTry for free, no card

Search company profiles

Vimachem

Full company profile

uuid0008qg4

Namestring
Vimachem
Websiteurl
vimachem.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Vimachem is a private, New York-based software company founded in 2018 that develops AI-driven Manufacturing Execution Systems (MES) for the pharmaceutical and biotechnology sectors. Its core product is a cloud-based MES platform purpose-built for regulated drug and biologics manufacturing environments, combining real-time production monitoring with AI-driven process optimization and automated regulatory compliance management. Vimachem targets drug manufacturers and biologics producers that require electronic batch records, quality control, and process visibility across manufacturing operations.

The platform is delivered as Software-as-a-Service on a recurring subscription basis, with implementation and integration services bundled into enterprise deployments. Vimachem goes to market through a direct enterprise field sales motion aimed at pharmaceutical and biotech manufacturers, supported by content marketing and industry thought leadership on AI applications in pharma MES. Distribution is described as global, though no specific country-level operating geographies are disclosed in available sources. The company employs between 11 and 50 people, with limited publicly verifiable information on funding, ownership structure, partnerships, or named customers.

Vimachem operates within the global bioprocess automation software market, which third-party sources size at approximately USD 1,998.8 million in 2025 with a projected CAGR of 12.6% through 2033. Despite operating in a growing market, the company remains a small, privately held vendor with no disclosed funding rounds, acquisitions, partnerships, or executive team beyond a single identified marketing manager. This data thinness constrains deeper strategic positioning conclusions and introduces uncertainty around competitive standing against larger incumbents.

Short descriptiontext

Vimachem is a private New York-based software company that develops an AI-driven, cloud-based Manufacturing Execution System (MES) for pharmaceutical and biotechnology manufacturers, serving regulated drug and biologics production environments via SaaS subscription and direct enterprise sales.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersQueens, United States
HQ citystring
Queens
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
pharmaceutical MES software, bioprocess automation, manufacturing execution systems, pharma compliance software, cloud manufacturing platform
Industry3 codes
PRIMARYIMAHAHAJ
Industrial Automation Software (SCADA, HMI, MES, Historian)
SECONDARYIMAIAMAA
Factory Automation & Control Systems (PLC/SCADA/DCS)
SECONDARYIMAGABAH
Process & Batch Control Software (Recipe Management, ISA-88)
Industrials, Manufacturing & Construction/Electrical Equipment & Industrial Electronics/Industrial Automation & Control Systems (PLCs, SCADA, DCS)
NAICS code1 code
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code1 code
  • Services-Computer Integrated Systems Design7373
Product category
Pharmaceutical Manufacturing Execution Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1MES Software Platform
TypeSubscription Recurring
Description

Software-as-a-Service model providing Manufacturing Execution Systems to pharmaceutical and biotech companies, with cloud-based deployment and AI capabilities for manufacturing process management

vimachem.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Vimachem develops and sells a cloud-based, AI-driven Manufacturing Execution System (MES) platform purpose-built for pharmaceutical and biotech manufacturers. The platform enables real-time production monitoring, AI-powered process optimization, automated regulatory compliance, and quality control across the drug manufacturing lifecycle. It is delivered as a SaaS solution targeted at regulated life science manufacturing facilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Improved data accuracy in pharmaceutical manufacturing
+3 more records
Product overview1 text field

Vimachem offers a unified AI-driven Pharma MES Platform — a cloud-based Manufacturing Execution System that combines real-time production monitoring, AI-powered process optimization, and automated compliance management for pharmaceutical and biotech manufacturers. The platform integrates AI capabilities to improve data accuracy, operational efficiency, and quality control across the manufacturing lifecycle.

Product and service1 record
1Vimachem AI-Driven Pharma MES Platform
CategoryPharmaceutical Manufacturing Execution Software (MES)
Description

Cloud-based, AI-powered Manufacturing Execution System designed for pharmaceutical and biotech manufacturers that enables real-time production monitoring, AI-driven process optimization, automated regulatory compliance, and quality control across the manufacturing lifecycle. Targeted at drug manufacturers and biologics producers needing validated MES functionality.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Tulip provides a cloud-based frontline operations / manufacturing execution platform with strong life sciences vertical focus. Most directly comparable to Vimachem in SaaS MES for regulated pharma/biotech manufacturing.

TypeBroad incumbent
Description

Emerson's Syncade MES is a leading pharma/biotech MES incumbent with deep installed base in life sciences. Most relevant broad incumbent competitor to Vimachem in pharma MES.

TypeEmerging player
Description

Kneat provides digital validation/CSV software for life sciences, overlapping with Vimachem's compliance automation value prop. Comparable as a SaaS entrant serving regulated pharma manufacturing with modern tooling.

TypeBroad incumbent
Description

Rockwell's Plex (cloud-native) and FactoryTalk MES platforms serve regulated manufacturers including life sciences. Comparable as an enterprise MES competitor with a cloud play.

TypeDirect peer
Description

Poka is a connected worker and manufacturing operations platform deployed across life sciences manufacturers. Comparable as a modern, cloud-based manufacturing execution and operations platform for regulated plants.

TypeDirect peer
Description

Apprentice offers a manufacturing execution and batch recording platform purpose-built for pharma and biotech. Closely comparable to Vimachem in product (MES) and vertical (life sciences).

7Siemens Digital Industries (Opcenter)
TypeBroad incumbent
Description

Siemens Opcenter (formerly SIMATIC IT) is a major enterprise MES platform with strong pharma/life sciences presence. Comparable as the legacy MES incumbent that Vimachem positions against.

TypeEmerging player
Description

MasterControl provides a quality/manufacturing platform for life sciences spanning QMS and production execution. Comparable as a regulated-pharma software peer with overlapping MES-adjacent capabilities.

TypeEmerging player
Description

ValGenesis provides digital validation lifecycle management software for life sciences. Comparable as a SaaS vendor serving pharma manufacturing compliance and validation, adjacent to Vimachem's compliance automation value prop.

TypeBroad incumbent
Description

Honeywell's life sciences QMS and MES offerings address pharma manufacturing compliance and execution. Comparable as a broad incumbent in regulated pharma operations software.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vimachem

Pharmaceutical Manufacturing Execution Softwarevimachem.com

Vimachem is a private New York-based software company that develops an AI-driven, cloud-based Manufacturing Execution System (MES) for pharmaceutical and biotechnology manufacturers, serving regulated drug and biologics production environments via SaaS subscription and direct enterprise sales.

What Vimachem does

Vimachem is a private, New York-based software company founded in 2018 that develops AI-driven Manufacturing Execution Systems (MES) for the pharmaceutical and biotechnology sectors. Its core product is a cloud-based MES platform purpose-built for regulated drug and biologics manufacturing environments, combining real-time production monitoring with AI-driven process optimization and automated regulatory compliance management. Vimachem targets drug manufacturers and biologics producers that require electronic batch records, quality control, and process visibility across manufacturing operations.

The platform is delivered as Software-as-a-Service on a recurring subscription basis, with implementation and integration services bundled into enterprise deployments. Vimachem goes to market through a direct enterprise field sales motion aimed at pharmaceutical and biotech manufacturers, supported by content marketing and industry thought leadership on AI applications in pharma MES. Distribution is described as global, though no specific country-level operating geographies are disclosed in available sources. The company employs between 11 and 50 people, with limited publicly verifiable information on funding, ownership structure, partnerships, or named customers.

Vimachem operates within the global bioprocess automation software market, which third-party sources size at approximately USD 1,998.8 million in 2025 with a projected CAGR of 12.6% through 2033. Despite operating in a growing market, the company remains a small, privately held vendor with no disclosed funding rounds, acquisitions, partnerships, or executive team beyond a single identified marketing manager. This data thinness constrains deeper strategic positioning conclusions and introduces uncertainty around competitive standing against larger incumbents.

Vimachem firmographics

Firmographics
Name
Vimachem
Website
https://vimachem.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
101–250 employees
Short description
Vimachem is a private New York-based software company that develops an AI-driven, cloud-based Manufacturing Execution System (MES) for pharmaceutical and biotechnology manufacturers, serving regulated drug and biologics production environments via SaaS subscription and direct enterprise sales.
Ownership category
akta.pro rank

Vimachem industry classification

Industry
Product category
Pharmaceutical Manufacturing Execution Software
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Services-Computer Integrated Systems Design (7373)
akta.pro industry
PRIMARYIMAHAHAJ
Industrial Automation Software (SCADA, HMI, MES, Historian)
SECONDARYIMAIAMAA
Factory Automation & Control Systems (PLC/SCADA/DCS)
SECONDARYIMAGABAH
Process & Batch Control Software (Recipe Management, ISA-88)
Industrials, Manufacturing & Construction/Electrical Equipment & Industrial Electronics/Industrial Automation & Control Systems (PLCs, SCADA, DCS)

Keywords

  • Pharmaceutical MES software
  • Bioprocess automation
  • Manufacturing execution systems
  • Pharma compliance software
  • Cloud manufacturing platform

Where Vimachem is headquartered

Location

Headquarters

HQ city
Queens
HQ country
United States
HQ region
North America

Markets served

Vimachem business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. MES Software Platform: Software-as-a-Service model providing Manufacturing Execution Systems to pharmaceutical and biotech companies, with cloud-based deployment and AI capabilities for manufacturing process management

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Vimachem product offering

Product offering

Core offering

Vimachem develops and sells a cloud-based, AI-driven Manufacturing Execution System (MES) platform purpose-built for pharmaceutical and biotech manufacturers. The platform enables real-time production monitoring, AI-powered process optimization, automated regulatory compliance, and quality control across the drug manufacturing lifecycle. It is delivered as a SaaS solution targeted at regulated life science manufacturing facilities.

Product overview

Vimachem offers a unified AI-driven Pharma MES Platform — a cloud-based Manufacturing Execution System that combines real-time production monitoring, AI-powered process optimization, and automated compliance management for pharmaceutical and biotech manufacturers. The platform integrates AI capabilities to improve data accuracy, operational efficiency, and quality control across the manufacturing lifecycle.

Differentiator

Problem solved

Functional benefit

Products and services

  • Vimachem AI-Driven Pharma MES Platform Cloud-based, AI-powered Manufacturing Execution System designed for pharmaceutical and biotech manufacturers that enables real-time production monitoring, AI-driven process optimization, automated regulatory compliance, and quality control across the manufacturing lifecycle. Targeted at drug manufacturers and biologics producers needing validated MES functionality.

Quantifiable outcome

  • Improved data accuracy in pharmaceutical manufacturing
  • +3 more outcomes

Companies that use Vimachem

Customer profile

Segments2 records

Ideal customer profiles2 records

Vimachem technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature1 record

Vimachem partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Vimachem competitors and assessment

Company assessment

Direct peers

  • Tulip Interfaces: Tulip provides a cloud-based frontline operations / manufacturing execution platform with strong life sciences vertical focus. Most directly comparable to Vimachem in SaaS MES for regulated pharma/biotech manufacturing.
  • Poka: Poka is a connected worker and manufacturing operations platform deployed across life sciences manufacturers. Comparable as a modern, cloud-based manufacturing execution and operations platform for regulated plants.
  • Apprentice.io: Apprentice offers a manufacturing execution and batch recording platform purpose-built for pharma and biotech. Closely comparable to Vimachem in product (MES) and vertical (life sciences).

Broad incumbents

  • Emerson (Syncade): Emerson's Syncade MES is a leading pharma/biotech MES incumbent with deep installed base in life sciences. Most relevant broad incumbent competitor to Vimachem in pharma MES.
  • Rockwell Automation (Plex / FactoryTalk): Rockwell's Plex (cloud-native) and FactoryTalk MES platforms serve regulated manufacturers including life sciences. Comparable as an enterprise MES competitor with a cloud play.
  • Siemens Digital Industries (Opcenter): Siemens Opcenter (formerly SIMATIC IT) is a major enterprise MES platform with strong pharma/life sciences presence. Comparable as the legacy MES incumbent that Vimachem positions against.
  • Honeywell (TrackWise / Movilizer): Honeywell's life sciences QMS and MES offerings address pharma manufacturing compliance and execution. Comparable as a broad incumbent in regulated pharma operations software.

Emerging players

  • Kneat Solutions: Kneat provides digital validation/CSV software for life sciences, overlapping with Vimachem's compliance automation value prop. Comparable as a SaaS entrant serving regulated pharma manufacturing with modern tooling.
  • MasterControl: MasterControl provides a quality/manufacturing platform for life sciences spanning QMS and production execution. Comparable as a regulated-pharma software peer with overlapping MES-adjacent capabilities.
  • ValGenesis: ValGenesis provides digital validation lifecycle management software for life sciences. Comparable as a SaaS vendor serving pharma manufacturing compliance and validation, adjacent to Vimachem's compliance automation value prop.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Vimachem social profiles

Digital presence

Vimachem financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vimachem leadership team

Management profile

Number of profiles

Profiles1 record

Vimachem funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vimachem M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vimachem

What does Vimachem do?

Vimachem develops and sells a cloud-based, AI-driven Manufacturing Execution System (MES) platform purpose-built for pharmaceutical and biotech manufacturers. The platform enables real-time production monitoring, AI-powered process optimization, automated regulatory compliance, and quality control across the drug manufacturing lifecycle. It is delivered as a SaaS solution targeted at regulated life science manufacturing facilities.

Is Vimachem a public or private company?

Vimachem is a private company. It is classified as unknown and is currently operating.

When was Vimachem founded?

Vimachem was founded in 2014. It employs 101 to 250 people.

Where is Vimachem based?

Vimachem is headquartered in Queens, United States, in the North America region.

How does Vimachem make money?

One revenue line is on record: MES Software Platform.

Who are Vimachem's main competitors?

Direct peers on record are Tulip Interfaces, Poka and Apprentice.io. Broad incumbents are Emerson (Syncade), Rockwell Automation (Plex / FactoryTalk), Siemens Digital Industries (Opcenter) and Honeywell (TrackWise / Movilizer). Emerging players are Kneat Solutions, MasterControl and ValGenesis.

Does Vimachem have an API?

No public API is recorded for Vimachem.

What industry is Vimachem in?

Vimachem's product category is Pharmaceutical Manufacturing Execution Software. Its primary akta.pro industry code is IMAHAHAJ, Industrial Automation Software (SCADA, HMI, MES, Historian), with a secondary code of IMAIAMAA, Factory Automation & Control Systems (PLC/SCADA/DCS). Its NAICS code is 33451 and its SIC code is 7373.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
VimachemWhat is Pharmaceutical Contract Manufacturing? Key AdvantagesThe article defines pharmaceutical contract manufacturing as a model where companies outsource production to specialized third-party providers like CMOs, CDMOs, and CPOs. It highlights key benefits including cost reduction, risk mitigation, and scalability, noting the global market is projected to grow from USD 172 billion in 2023 to approximately USD 330.52 billion by 2033. The text also outlines regulatory requirements such as FDA Quality Agreements and introduces Vimachem's AI-driven Manufacturing Execution System (MES) as a tool to support compliance and efficiency.VimachemPharmaceutical Industry Trends: Innovations Shaping the FutureThe article outlines emerging trends in the pharmaceutical industry, highlighting the adoption of AI, gene editing, and continuous manufacturing to enhance efficiency and personalization. It details how technologies like IIoT and digital platforms are transforming production, regulatory compliance, and patient engagement. Vimachem is promoted as a provider of MES solutions supporting these digital transformations.VimachemPharma MES: AI In Pharma Manufacturing Execution SystemsThe article discusses the integration of artificial intelligence (AI) into Pharmaceutical Manufacturing Execution Systems (MES), specifically through Vimachem’s AI-driven Pharma MES platform. It highlights the benefits of AI in improving data accuracy, compliance, process optimization, and operational efficiency in pharma manufacturing.